Cardiol Therapeutics Inc. (CRDL)
NASDAQ: CRDL · Real-Time Price · USD
1.940
+0.060 (3.19%)
Aug 30, 2024, 4:00 PM EDT - Market closed

Cardiol Therapeutics Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
6
Market Cap
135.16M USD

Revenue Chart

* This company reports financials in CAD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 202178.76K--
Dec 31, 2020---
Dec 31, 2019---
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
InfuSystem Holdings 129.37M
Harvard Bioscience 101.13M
Repare Therapeutics 68.68M
Electromed 54.72M
BrainsWay 36.43M
Elutia 24.99M
CervoMed 9.65M
Quantum-Si incorporated 1.70M
Revenue Rankings